These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27109558)

  • 21. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ; White RD
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence.
    Barag SH
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S13-9. PubMed ID: 21813731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacist's role in maintaining adherence to insulin therapy in type 2 diabetes mellitus.
    Vivian EM
    Consult Pharm; 2007 Apr; 22(4):320-32. PubMed ID: 17658964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to insulin progression among patients with type 2 diabetes: a systematic review.
    Polinski JM; Smith BF; Curtis BH; Seeger JD; Choudhry NK; Connolly JG; Shrank WH
    Diabetes Educ; 2013; 39(1):53-65. PubMed ID: 23192599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
    Nadeau DA
    Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
    Cobble ME
    Am J Ther; 2009; 16(1):56-64. PubMed ID: 19142156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for improving adherence to type 2 diabetes mellitus therapy--focus on optimizing insulin-based therapy.
    Campbell RK
    Am J Manag Care; 2012 Apr; 18(3 Suppl):S55-61. PubMed ID: 22558943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Building cultural competency for improved diabetes care: Latino Americans and diabetes.
    Cabellero AE; Tenzer P
    J Fam Pract; 2007 Sep; 56(9 Suppl Building):S7-13. PubMed ID: 18667137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
    Nadeau DA
    Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal-bolus insulin therapy and glycemic control in adult patients with type 2 diabetes mellitus: a review of the literature.
    Jackson B; Grubbs L
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):348-52. PubMed ID: 24170333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
    Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
    Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM; Borgman SK
    Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removing barriers to insulin use.
    Minze MG; Dalal K; Irons BK
    J Fam Pract; 2011 Oct; 60(10):577-80. PubMed ID: 21977484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.
    Eliaschewitz FG; de Paula MA; Pedrosa HC; Pires AC; Salles JEN; Tambascia MA; A Turatti LA
    Diabetes Metab Syndr; 2018; 12(1):39-44. PubMed ID: 28864058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing barriers to initiation of insulin in patients with type 2 diabetes.
    Peyrot M; Rubin RR; Khunti K
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S11-8. PubMed ID: 20394886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.